Breaking Finance News

A report released today by Numis about Spire Healthcare Group (LON:SPI) holds the target price at 360.00GBX

Just yesterday Spire Healthcare Group (LON:SPI) traded -8.87% lower at 315.00GBX. SPI’s 50-day average is 348.30GBX and its two hundred day average is 352.87GBX. With the last close down -10.87% from the 200-day moving average, compared to the S&P 500 which has decreased -0.05% over the date range. Volume of trade was up over the average, with 992,590 shares of SPI changing hands over the typical 386,078

Spire Healthcare Group (LON:SPI) had its target price hold steady to 360.00GBX by Numis in a report released 1/12/2017. The new target price indicates a possible upside of 0.14% based on the company's last stock close price.

Previously on Wednesday January 04, 2017, JP Morgan Cazenove reported about Spire Healthcare Group (LON:SPI) held steady the target price at 433.00GBX. At the time, this indicated a possible upside of 0%.

Performance Chart

Spire Healthcare Group (LON:SPI)

With a total market value of 0 GBX, Spire Healthcare Group has price-earnings ratio of 19.53 with a 52 week low of 295.00GBX and a 52 week high of 411.00GBX .

In addition to Numis reporting its stock price target, a total of 7 brokers have issued a report on the company. The average stock price target is 57.14GBX with 1 broker rating the stock a strong buy, 4 brokers rating the stock a buy, 4 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell.

General Information About Spire Healthcare Group (LON:SPI)

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services. The Company offers a range of primary care, consulting and diagnostic services. The Company's serves a patient mix consisting of private medical insurance (PMI), self-pay and National Health Service (NHS) patients. The Company's primary activities include diagnostics, such as imaging, magnetic resonance imaging or computerized tomography scanning and pathology; out-patient services, such as consulting, treatments, health checks and physiotherapy, and in-patient daycase procedures, such as orthopedics, cardiology, neurology, oncology and general surgery.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.